WHAT DOES
THE SUN
LEAVE BEHIND?

Sun damage — more precisely, photodamage or photoaging — refers to changes in the skin associated with cumulative exposure to ultraviolet (UV) radiation. It is distinct from chronological aging, which is the skin's natural progression over time. Photoaging is what the environment adds to that progression. Both are normal. Neither is a moral failing.

Photodamage may appear as pigment changes (freckles, sun spots, uneven tone), texture changes (roughness, fine lines), vascular changes (visible vessels, redness), or a loss of the even clarity associated with less-exposed skin. Because UV exposure accumulates over years, the signs often become more visible gradually — and because they accumulate, the way they are treated should reflect what is actually there, not a single word applied to every mark.

Sun damage is not one appearance. It is a family of changes, and a single person may show several at once. Different manifestations may respond to different treatments — which is why naming the concern matters before naming the device.

Not every brown spot belongs in a cosmetic conversation. A spot that is new, changing, unusual in shape or color, growing, bleeding, symptomatic, or otherwise concerning should be medically evaluated — not treated cosmetically. This is not about alarm; it is about sequence. Medical evaluation comes first, cosmetic treatment comes after.

This article does not diagnose melanoma, and it does not encourage self-diagnosis. It simply states a principle: when something on the skin is changing or unusual, the correct next step is evaluation by an appropriate medical professional — not a laser appointment. If a lesion is cleared medically, a cosmetic conversation about its appearance can follow.

Sun spots — solar lentigines — are flat pigment patches associated with cumulative sun exposure. They commonly appear on areas that receive the most sun over a lifetime: the face, the backs of the hands, the chest, the neck, and the forearms. They differ from freckles in their relationship to exposure: freckles may darken and fade with UV, while solar lentigines tend to persist.

Cumulative exposure is the key idea. A sun spot is, in a sense, a record of exposure over time — which is why they often appear later and why they tend to remain. Treating them is a cosmetic conversation about appearance; protecting against more is a long-term conversation about skin health.

Freckles and sun spots are both pigment marks, but they are not the same thing, and they may behave differently over time and with exposure.

Visual self-identification is not always reliable. Two marks that look similar to the eye may be different things, and the difference can matter for treatment. A consultation helps clarify what is present before a plan is built.

Sun spots and melasma are not interchangeable. They differ in distribution, triggers, recurrence, and complexity — and because of that, laser treatment planning differs for each.

Sun spots are typically discrete patches associated with cumulative exposure. Melasma is often more diffuse, may appear in characteristic patterns (such as the cheeks, forehead, and upper lip), and is influenced by multiple triggers including UV, hormones, and inflammation. Melasma is also often recurrent — it may improve and return. Treating melasma as if it were a simple sun spot can lead to frustration and, in some cases, worsening.

A LASER THAT MAKES SENSE FOR ONE TYPE OF PIGMENT MAY NOT MAKE SENSE FOR ANOTHER.

Not every dark mark is sun damage. Post-inflammatory hyperpigmentation (PIH) is darkening that follows inflammation — after acne, after irritation, after a procedure, after any injury to the skin. It is common, especially in richer skin tones, and it is a different conversation from photodamage.

PIH may improve over time and with appropriate skincare, and certain treatments may help. But assuming every dark mark is sun damage can lead to the wrong plan. A mark that followed a breakout, a rash, or a procedure has a different history — and that history matters for treatment selection.

ULTRA works in a sequence: energy is delivered to the surface in a fractional pattern, the treated microzones stimulate a skin-revitalization response, and the surrounding untreated tissue supports healing and remodeling. Over time, that remodeling is what may produce visible change in tone and texture.

The platform uses a 200 μm microbeam with magnetic roller tracking (IntelliTrak) and Controlled Chaos Technology to help keep energy delivery consistent across the treatment area. The mechanism targets water rather than pigment alone, which is why the conversation around ULTRA is about overall skin quality, not only individual spots.

ULTRA's cleared indications include benign pigmented lesions such as lentigos and solar lentigos. That means it may be an appropriate technology for certain brown spots — when those spots have been identified as the type of pigment ULTRA is cleared to treat, and when the skin tone and pigment history support it.

Which brown spots ULTRA may improve, and which it may not, depends on the diagnosis. A confirmed sun spot within cleared indications is a different conversation from melasma, from PIH, or from a lesion needing evaluation. Settings matter, skin tone matters, and expectations matter. ULTRA is not a promise to remove every brown spot; it is a technology that may improve certain benign pigment concerns where the conditions align.

JOLA does not promise removal. The language is about improvement — softening the appearance, reducing visibility — within what the technology and the individual skin support.

Solar lentigines (sun spots) are among ULTRA's cleared pigment indications. Where a sun spot has been identified and the skin is appropriate, ULTRA may be a reasonable technology to explore. The goal is realistic improvement — softening the appearance of the spot — not erasure.

Because sun spots are a record of cumulative exposure, treating one does not change the fact of that exposure. Visible improvement may be possible; ongoing protection is what helps keep the result from being undone by continued UV. A consultation at JCLA Dallas helps determine whether ULTRA fits a particular sun spot and a particular skin.

Ephelides (freckles) are also among ULTRA's cleared pigment indications. Freckles may respond to laser, but they also have a relationship with UV exposure — they may darken with continued sun and, in some cases, recur. Treating freckles is therefore not the same as permanently removing them.

A patient who wants to soften the appearance of freckling may explore ULTRA where appropriate. A patient who expects freckles never to return is setting up a different conversation. Continued UV exposure matters, and so does the natural behavior of freckles over time. Honest expectations are part of the plan.

"Uneven tone" can mean several things: pigmentation, redness, post-inflammatory marks, sun spots, melasma, or surface dullness. Each has a different cause, and each may need a different approach. ULTRA is one option among several, and it fits some of these conversations better than others.

When uneven tone is driven by the pigment concerns ULTRA is cleared for, it may be a fit. When the unevenness is vascular, or driven by melasma, or by surface dullness alone, the conversation may point elsewhere. Identifying what "uneven" actually means for a given face is the step that makes treatment selection precise.

Cumulative sun exposure affects more than pigment. It may also affect texture — roughness, surface irregularity, and a general loss of smoothness. ULTRA's mechanism, which targets water in tissue and stimulates a skin-revitalization response, is relevant to this textural conversation, not only to pigment.

Where textural change from photoaging is the concern, ULTRA may have a role in improving roughness and surface quality. This is part of why ULTRA is described as a skin-quality laser rather than only a spot-removal device. For the full texture and pores conversation, see the foundational ULTRA laser guide.

There is a difference between fine surface lines associated with photoaging and dynamic expression lines caused by muscle movement. ULTRA may have a role in the surface-line conversation, where the lines are related to cumulative exposure and skin quality.

When movement is the primary cause — the lines that appear with expression and deepen over time — neuromodulators are a different category. Botox and Dysport address the muscle movement that creates dynamic lines; a laser does not. A patient may have both concerns and benefit from different categories for each.

For the dynamic-line conversation, see Botox and Dysport at JOLA Dallas.

ULTRA is not primarily a vascular treatment. Its wavelength and mechanism are oriented toward pigment and skin quality, not toward visible vessels or diffuse redness. Visible redness and small vessels from sun damage are often a different conversation, and may be better suited to a technology designed for vascular concerns.

Saying so directly is part of building trust. Not every sign of sun damage is a pigment problem, and not every device solves every concern. A patient whose sun damage includes redness may need a different technology, or a combination plan, rather than a single laser applied to everything.

NOT EVERY SIGN OF SUN DAMAGE IS A PIGMENT PROBLEM.

Melasma is complex, often recurrent, and influenced by multiple triggers — UV, hormones, inflammation. It is not a simple sun spot, and it should not be treated as one. Laser is not automatically first-line for melasma, and whether laser fits at all depends on the individual, the type of melasma, the skin tone, and the history.

JOLA does not say ULTRA cures melasma. Where there is evidence for a laser's role in melasma, it is represented precisely; where the evidence is limited or the risk higher, that is stated plainly. Melasma treatment is individualized, often begins with skincare and photoprotection, and may or may not include laser. That decision is made in consultation, not assumed.

This is one reason the article keeps returning to the same idea: identify the pigment before choosing the device. Melasma is the clearest example of why that matters.

Laser energy is an injury to the skin, and injury can trigger pigment. Post-inflammatory hyperpigmentation is a real risk with any pigment-relevant treatment, and it is more relevant in richer skin tones and in patients with a history of pigment darkening. This is not fearmongering; it is the reason treatment selection and settings matter.

Skin tone, pigment history, device choice, treatment intensity, recent sun exposure, aftercare, and individual biology all influence whether a treatment improves pigment or provokes more. A lower, more conservative setting on the right skin may be more appropriate than an aggressive setting that risks PIH. This is where provider judgment becomes central — the same device can help or harm depending on how it is used.

"Safe for all skin tones" is too absolute a claim for any pigment-relevant device unless manufacturer evidence explicitly supports it. What can be said is that ULTRA's non-ablative fractional mechanism and 1927 nm wavelength are considerations in how it is used across Fitzpatrick skin types, and that PIH risk is a real factor in richer skin tones.

In practice, this means settings, conservative delivery, and a careful pigment history matter more in darker skin tones — not that treatment is impossible, but that it requires judgment. A provider who understands melanin, PIH risk, and the difference between skin types is essential. At JOLA Dallas, that judgment is part of the consultation, not an afterthought.

Read more about ULTRA and darker skin tones in the foundational ULTRA laser guide.

Before a laser is chosen, a provider may ask questions that seem unrelated to the spot itself. They are not unrelated. They are how a thoughtful clinician assesses how the skin is likely to respond — and how to avoid making pigment worse.

Laser may improve the visible signs of photodamage — softening pigment, refining texture, addressing tone. It does not erase cumulative biological exposure, and it does not make future sun protection unnecessary. "Reverse" is not a promise JOLA makes.

TREATING THE EVIDENCE OF SUN EXPOSURE DOES NOT REMOVE THE NEED TO PROTECT THE SKIN FROM MORE OF IT.

Treated visible pigment may improve, but new pigmentation can develop, and certain pigment can recur depending on the condition. Sun exposure continues. Aging continues. Individual pigment biology continues. A treatment is not a lifetime exemption from photoprotection.

For conditions like melasma, recurrence is part of the condition. For sun spots, new ones may develop with continued exposure. For freckles, darkening may return with UV. This is why protection and reassessment are part of the plan, not optional add-ons.

Reducing new UV-related change after treatment depends on photoprotection: broad-spectrum sunscreen at an appropriate SPF per current dermatologic guidance, protective clothing, shade, sensible sun-avoidance strategies, and skincare recommended by the treating provider. These are not generic filler — they are how a result is maintained.

A patient who treats sun spots and then stops protecting the skin is likely to see the conversation restart. Protection is part of the treatment. For a skincare plan built around your skin, explore clinical skincare at JOLA Dallas.

No. Sunscreen is primarily protective. It reduces additional UV-related change; it does not function like a resurfacing laser. Sunscreen will not lift an existing sun spot the way a pigment-relevant treatment may.

But photoprotection may be essential to maintaining results and reducing additional change. The two work together: treatment addresses what is present, protection addresses what comes next. One does not replace the other.

Topical retinoids may improve aspects of photoaging — tone, texture, the quality of the skin surface — depending on formulation and use. They are a valuable tool. But skincare and procedural treatments are different tools, and they do different things.

Skincare is not useless, and it is not a replacement for a pigment-relevant laser when a spot is the concern. Often the strongest plan uses both: skincare for daily maintenance and surface quality, and a treatment like ULTRA for the pigment that skincare alone does not address. For a personalized regimen, explore clinical skincare at JOLA Dallas.

Both may address pigment, but they are different technologies with different light sources, depth profiles, and skin-tone considerations. Neither is a universal winner; the choice depends on the pigment, the skin tone, and the goal.

As with IPL, the comparison is between a laser and a light-based technology. Mechanism, wavelength specificity, and downtime differ. The right choice follows the concern and the skin, not a brand preference.

For the full ULTRA laser vs. IPL/BBL comparison — laser vs pulsed light for sun damage, brown spots, redness, pigmentation, texture, downtime, skin tones, and how to choose — read the dedicated color study.

Both may address pigment and texture, but through different mechanisms. Depth, recovery, skin-tone considerations, and customization differ. A peel may be more appropriate for some patients; a laser for others.

Microneedling may help certain textural concerns, but it does not target pigment in the same manner as a pigment-relevant laser. When sun spots are the primary concern, the technology should reflect that.

For the full ULTRA laser vs. microneedling comparison — laser vs traditional microneedling for sun damage, pigment, texture, scars, downtime, and skin tone — read the dedicated surface/structure study.

RF microneedling is not primarily a pigment technology. If pigmentation is the primary concern, treatment selection should reflect that. The two may complement each other in a combined plan, but they are not interchangeable.

CO₂ represents a different resurfacing intensity. The comparison is about surface ablation, downtime, texture, pigment, and fine lines — not equivalent results. One is not simply 'better'; they serve different points on the intensity-to-recovery curve.

Fraxel is a brand family, not a single wavelength. The current Fraxel Dual platform offers 1550 nm and 1927 nm wavelengths. ULTRA operates at 1927 nm — the same wavelength category as the 1927 nm Fraxel component — which makes them directly comparable for sun-damage concerns. But sharing a wavelength does not mean the devices, settings, or outcomes are identical.

For the full specification-led ULTRA vs. Fraxel comparison — including wavelength, target, depth, downtime, and skin-tone considerations — read the dedicated guide.

A patient can have sun damage and skin laxity at the same time. ULTRA and XERF address different concerns, and they are not interchangeable. ULTRA is a laser for skin quality — pigment, tone, texture, surface renewal. XERF is radiofrequency for skin firmness and laxity. One addresses what the sun did to the surface; the other addresses what time and gravity did to the structure.

ONE FACE. TWO DIFFERENT CONCERNS. TWO DIFFERENT TECHNOLOGIES.

For the firmness and laxity conversation, explore XERF at JOLA Dallas.

Conceptually, yes. A patient with both pigment and laxity may benefit from a plan that uses different technologies for different concerns. The framework is simple: if the concern is pigment and texture, explore ULTRA. If the concern is firmness and laxity, explore XERF. If both are present, consultation-led combination planning may be appropriate.

JOLA does not invent treatment order or intervals here. Sequence, spacing, and intensity are determined in consultation based on the skin, the concerns, and the goals — not assumed in an article.

Botox and Dysport address dynamic muscle movement — the lines created by expression. They do not treat sun spots. A patient with forehead lines and sun damage has two different concerns, and they need different categories.

Reinforcing the principle: concern, then category, then treatment. Movement is a neuromodulator conversation; pigment is a laser conversation. For the dynamic-line conversation, see Botox and Dysport at JOLA Dallas.

Dermal filler changes structure and volume — it restores contours, balances proportions, and supports the face. It does not treat sun spots. Filler is a structural conversation; pigment is a surface conversation.

Again: concern, then category, then treatment. A patient may benefit from both, but they are not the same tool. For the structural conversation, see facial balancing at JOLA Dallas.

Sculptra is a collagen biostimulator — a volume-support and structural conversation. It is not a surface pigmentation or photoaging conversation. Like filler, it addresses a different layer and a different concern.

A patient with volume loss and sun damage may have a plan that includes both, but the technologies serve different goals. For the biostimulation conversation, see Sculptra at JOLA Dallas.

The sensation of an ULTRA treatment is something best described in consultation rather than by a pain score. Patients commonly describe a warming or prickling sensation as the fractional energy is delivered across the skin. Comfort management, including numbing where appropriate, is part of how JOLA approaches the experience.

Treatment duration depends on the area being treated. The goal is a tolerable, controlled experience — not the absence of sensation. For a fuller description, see the foundational ULTRA laser guide.

After ULTRA, the skin may show a response consistent with a fractional non-ablative treatment — which can include redness, dryness, roughness, mild swelling, bronzing, or flaking as the skin moves through its healing response. The specific experience depends on the settings, the area, and the individual.

JOLA does not copy generic fractional-laser recovery here. The expected effects are described based on ULTRA's mechanism and current manufacturer guidance, and a patient receives specific aftercare instructions for their treatment. For the complete recovery overview, see the ULTRA laser guide.

There is a difference between skin response — what the skin is doing as it heals — and social downtime — how much of that response is visible to others. ULTRA's non-ablative fractional mechanism is associated with less downtime than more aggressive ablative resurfacing, but it is not zero downtime.

JOLA does not promise zero downtime. The honest framing is that ULTRA is a real treatment with a real skin response, generally shorter than ablative alternatives, and planned around the patient's schedule.

Pigment response and texture response may not follow identical timelines. Visible change in pigment depends on the type of pigment, the settings, the skin, and the healing response. Collagen-related changes — the texture and quality improvements — develop over a different, longer curve.

Rather than inventing a specific day or week, JOLA sets expectations in consultation based on the individual plan. What can be said generally: pigment and texture are different processes, and they improve on different schedules.

With some fractional laser treatments, treated pigment may temporarily darken or bronze before it sheds — a normal part of the skin's response as the pigment comes to the surface. Whether this occurs with ULTRA, and to what degree, depends on the settings and the individual.

Where this is an expected ULTRA response supported by current manufacturer guidance, it is explained in consultation so the patient is not surprised. JOLA does not generalize from other laser systems; the description is specific to ULTRA's mechanism.

The number of treatments depends on the type of pigment, the degree of photodamage, the treatment intensity, the skin tone, the response, and the goals — within the manufacturer's protocol. There is no universal number that applies to every face.

JOLA does not use package-driven language. A plan is built around what the skin needs and what the patient wants to see, reassessed as the skin responds. Some concerns may be addressed in a series; some may need less; some may point to a different technology entirely.

For the full treatment-count conversation, see the ULTRA laser guide.

JOLA does not begin with "which laser package should we sell." It begins with a question: what are we seeing? Is it pigment, texture, redness, fine lines, laxity, volume, or a combination? Then the conversation determines which treatment category actually fits.

A DEVICE SHOULD FOLLOW THE DIAGNOSIS OF THE AESTHETIC CONCERN. NOT THE OTHER WAY AROUND.

That is the philosophy behind every laser for sun damage Dallas conversation at JOLA — and it is why the consultation comes first. For more, see JOLA's treatment philosophy.

A saveable checklist for the consultation. The right questions tend to produce the right plan.

FAQ

Frequently Asked Questions